DSE, Inc.:企業の戦略・SWOT・財務分析

◆英語タイトル:DSE, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY5062
◆発行会社(調査会社):MarketLine
◆発行日:2020年1月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Aerospace and Defense
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

DSE, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

DSE, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

DSE, Inc. (DSE) designs, manufactures, develops and markets a wide range of precision metal components, assemblies and ordnance products. The company’s product portfolio consists of both low velocity and high velocity ammunition products. Its low velocity ammunition products include M781 Practice (Orange Dye), M433 High Explosive Dual Purpose (HEDP) and M992 Dummy Cartridge. The company also offers a comprehensive range of high velocity ammunition products including M385A1 Practice, M918 Practice (Flash-Bang) and M430 High Explosive Dual Purpose. It is currently one of the world’s prime contractors of the US Army for 40mm ammunition. DSE is headquartered in Tampa, Florida, the US.

Scope

- Detailed information on DSE, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting DSE, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of DSE, Inc. including a breakdown and examination of key business segments
- Intelligence on DSE, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about DSE, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of DSE, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess DSE, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on DSE, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
DSE, Inc.: Company Overview
DSE, Inc.: Overview and Key Facts
DSE, Inc.: Overview
DSE, Inc.: Key Facts
DSE, Inc.: Major Products and Services
DSE, Inc.: Company History
DSE, Inc.: Key Competitors
DSE, Inc.: Company Analysis
DSE, Inc.: Business Description
DSE, Inc.: SWOT Analysis
DSE, Inc.: SWOT Overview
DSE, Inc.: Strengths
DSE, Inc.: Weaknesses
DSE, Inc.: Opportunities
DSE, Inc.: Threats
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: DSE, Inc.: Key Facts
Table 2: DSE, Inc.: Company History
Table 3: DSE, Inc.: Key Competitors

★海外企業調査レポート[DSE, Inc.:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ONGC Videsh Ltd:企業のM&A・事業提携・投資動向
    ONGC Videsh Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ONGC Videsh Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Mercury NZ:戦略・SWOT・企業財務分析
    Mercury NZ - Strategy, SWOT and Corporate Finance Report Summary Mercury NZ - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • The Scripps Research Institute:企業のM&A・事業提携・投資動向
    The Scripps Research Institute - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Scripps Research Institute Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Pampa Energia SA (PAMP):石油・ガス:M&Aディール及び事業提携情報
    Summary Pampa Energia SA (Pampa) is an independent integrated energy company. It generates, distributes and transmits electricity; and explores and produces, refines oil and gas, and petrochemicals and commercializes and transports them. The company produces electricity using coal, wind, hydro, and …
  • Twenty-First Century Fox Inc. (FOXA):企業の財務・戦略的SWOT分析
    Twenty-First Century Fox Inc. (FOXA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • National Health Insurance Company – Daman PJSC:企業の戦略・SWOT・財務分析
    National Health Insurance Company – Daman PJSC - Strategy, SWOT and Corporate Finance Report Summary National Health Insurance Company – Daman PJSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • BTG Plc (BTG):製薬・医療:M&Aディール及び事業提携情報
    Summary BTG plc (BTG) develops, manufactures and sells medicines for acute care, cancer and vascular diseases. The company develops specialty drugs including antidotes for snake envenomation and toxicity related to medicines used for heart conditions and cancer; interventional vascular products for …
  • Biovica International AB (BIOVIC B):医療機器:M&Aディール及び事業提携情報
    Summary Biovica International AB (Biovica) is a biotech company that focuses on the development and commercialization of blood-based biomarker assays. The company’s DiviTum is a biomarker test that has been developed to monitor and predict treatment effectiveness in the treatment of solid tumours. D …
  • Hotel Royal Limited:戦略・SWOT・企業財務分析
    Hotel Royal Limited - Strategy, SWOT and Corporate Finance Report Summary Hotel Royal Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Group Five Ltd:企業の戦略的SWOT分析
    Group Five Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Kuwait Petroleum Corp:企業の戦略的SWOT分析
    Kuwait Petroleum Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Citibank Berhad:企業の戦略的SWOT分析
    Citibank Berhad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • BoneSupport AB:医療機器:M&Aディール及び事業提携情報
    Summary BoneSupport AB (BoneSupport), a subsidiary of Bonesupport Holding AB, is a orthobiologics company that develops, manufactures and markets injectable bioceramic bone graft substitutes for the treatment of fragility fractures caused by osteoporosis; bone voids and gaps caused by trauma; infect …
  • Dai Nippon Printing Co Ltd (7912):企業の財務・戦略的SWOT分析
    Dai Nippon Printing Co Ltd (7912) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Provectus Biopharmaceuticals Inc (PVCT):企業の財務・戦略的SWOT分析
    Summary Provectus Biopharmaceuticals Inc (Provectus) is a developer of pharmaceuticals for oncology and dermatology indications. The company provides pipeline products such as PV-10 for locally advanced cutaneous melanoma, PV-10 for metastatic liver cancer and PV-10 for neuroendocrine tumors [NET], …
  • Astrazeneca Pharma India Ltd (ASTRAZEN):企業の財務・戦略的SWOT分析
    Summary AstraZeneca Pharma India Ltd (AstraZeneca), a subsidiary of AstraZeneca Plc, is a biopharmaceutical company. It discovers, develops, supplies and commercializes medicines. The company’s product portfolio include Forxiga, Imdur, Crestor, Tagrisso, Lynparza, Betaloc, Symbicort, budesonide, for …
  • Ranhill Holdings Berhad (RANHILL):企業の財務・戦略的SWOT分析
    Ranhill Holdings Berhad (RANHILL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Accrol Group Holdings PLC (ACRL):企業の財務・戦略的SWOT分析
    Accrol Group Holdings PLC (ACRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Sao Martinho SA (SMTO3):企業の財務・戦略的SWOT分析
    Sao Martinho SA (SMTO3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Molecular Templates Inc (MTEM):製薬・医療:M&Aディール及び事業提携情報
    Summary Molecular Templates Inc (MTI), formerly Threshold Pharmaceuticals Inc, is a clinical-stage oncology company that discovers and develops biologic therapeutics for cancer. The company’s pipeline products include MT-3724, MT-4019, MT-5111, MT-5050 and MT-6868. Its lead product MT-3724, a fusion …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆